UnitedHealth Group Incorporated

USD, fiscal year ended 2024-12-31

Revenue: Top segments reported by the source sum to more than $400.3B of revenue (a known FMP double-count pattern) - painted without v2 source/hub tags

Operating Expenses: R&D 0% | SG&A 0% of revenue

Revenue

$400.3B+7.7%

Gross margin

22.3%-2.1 pts

Operating margin

8.1%-0.6 pts

Net margin

3.6%-2.4 pts

Open full screen

Revenue segments

Unitedhealthcare: $298.2B74.5%
Optumrx: $133.2B33.3%
Optumhealth: $105.4B26.3%
Optuminsight: $18.8B4.7%

Period history

Revenue, by year

Income statement

Line	FY2024	YoY
Revenue	$400,278,000,000	+7.7%
Cost of revenue	$310,879,000,000	+11%
Gross profit	$89,399,000,000	-1.7%
Operating expenses	$57,112,000,000	-2.5%
Operating income	$32,287,000,000	-0.2%
Other income/expense, net	-$12,216,000,000	-276%
Income before tax

UnitedHealth Group Incorporated

Revenue segments

Period history

Income statement

More in Healthcare

Eli Lilly and Company

Johnson & Johnson

Pfizer Inc.